HAVCR2 and breast cancer: Additionally, the co-blockade of PD-1 and PD-L1 downregulated CTLA-4 expression in CD4+ CD25− T-cells but upregulated the co-expression of TIM-3 and LAG-3 in CD4+ CD25+ T-cells within the BC cells [120].